[Effect of postoperative chemotherapy on treatment effectiveness in breast cancer].
The analysis of the course and issues of the disease in 1424 patients with operable cancer of the mammary gland indicated that using of the postoperative chemotherapy increases a 5-year survival without recurrences and metastases, on an average, by 10%, while in early tumors (without regional metastases)--by 15-20%. Moreover, in patients subjected to chemotherapy distant metastases appear in later terms than in those without it.
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008408:Mastectomy; D011182:Postoperative Care / Q000379:methods*; D013852:Thiotepa / Q000008:administration & dosage
D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil
Vliianie posleoperatsionnoĭ khimioterapii na éffektivnost' lecheniia raka molochnoĭ zhelezy.